Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Foralumab in Genotype-I Chronic Hepatitis C Non-responders
NCT01459419Phase 2Unknown
- Sponsor
- Inspira Health
- Start
- Nov 2011
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of foralumab in hepatitis C (HCV), sponsored by Inspira Health. Status: unknown.
02
Drugs
foralumab
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01459419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459419.